Update on PET glucose neuroimaging

International Review of Psychiatry

Volumn 9, Issue 4, 1997, Pages 339-354

  Buchsbaum, Monte S ^a   Hazlett, Erin A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DEOXYGLUCOSE; GLUCOSE; NEUROLEPTIC AGENT; SEROTONIN AGONIST; UNINDEXED DRUG;

BRAIN FUNCTION; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM FUNCTION; CORPUS STRIATUM; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; TEMPORAL LOBE; THALAMUS;

EID: 0030664544     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.1080/09540269775213     Document Type: Review

References (96)

1. ANDREASEN, N. C., ARNDT, S., SWAYZE, V. II, CIZADLO, T., FLAUM, M., O'LEARY, D., EHRHARDT, J. C. & YUH, W. T. C. (1994). Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science, 266, 294-298.
2. ANDREASEN, N. C., O'LEARY, D. S., CIZADLO, T., ARNDT, S., REZAI, K., WATKINS, L., PONTO, L. L. & HICHWA, R. D. (1995). Remembering the past: two facets of episodic memory explored with positron emission tomography. American Journal of Psychiatry, 152, 1576-1585.
3. ANDREASEN, N. C., REZAI, K., ALLIGER, R., SWAYZE, V. W., FLAUM, M., KIRCHNER, P., COHEN, G. & O'LEARY, D. S. (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia, Archives of General Psychiatry, 49, 943-958.
4. ANDREASON, P. J., ZAMETKIN, A. J., GUO, A. C., BALDWIN, P. & COHEN, R. M. (1994). Gender-related differences in regional cerebral glucose metabolism in normal volunteers. Psychiatry Research, 51, 175-183.
5. ARNDT, S., RAJARETHINAM, R., CIZADLO, T., O'LEARY, D., DOWNHILL, J. & ANDREASEN, N. C. (1996). Landmark-based registration and measurement of magnetic resonance images: a reliability study. Psychiatry Research: Neuroimaging, 67, 145-154.
6. AZARI, N. P., PETTIGREW, K. D., PIETRINI, P., MURPHY, D. G., HORWITZ, B. & SCHAPIRO, M. B. (1995). Sex differences in patterns of hemispheric cerebral metabolism: a multiple regression/discriminant analysis of positron emission tomographic data. International Journal of Neuroscience, 81, 1-20.
7. AZARI, N. P., RAPOPORT, C. L, GRADY, C. L., DECARLI, C., HAXBY, J. V., SCHAPIRO, M. B. & HORWITZ, B. (1992). Gender differences in correlations of cer-ebral glucose metabolic rates in young normal adults. Brain Research, 574, 198-208.
8. BARTELS, P. H. & SUBACH, J. A. (1976). Significance probability mapping and automated interpretation of complex pictorial scenes, in: E. PRESTON & M. ONOE (Eds), Digital processing of biomedical imagery (pp. 101-114). New York: Academic Press.
9. BARTLETT, E. J., BAROUCHE, F., BRODIE, J. D., WOLKIN, A., ANGRIST, B., ROTROSEN, J. & WOLF, A. P. (1991a). Stability of resting deoxyglucose metabolic values in PET studies of schizophrenia. Psychiatry Research: Neuroimaging, 40, 11-20.
10. BARTLETT, E. J., BRODIE, J. D., SIMKOWITZ, P., DEWEY, S. L., RUSINEK, H., WOLF, A. P., FOWLER, J. S., VOLKOW, N. D., SMITH, G. & WOLKIN, A. (1994). Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. American Journal of Psychiatry, 151, 681-686.
11. BARTLETT, E. J., BRODIE, J. D., SIMKOWITZ, P., DEWEY, S. L., RUSINEK, H., VOLKOW, N. D., WOLF, A. P., SMITH, G., WOLKIN, A. & CANCRO, R. (1996). Time-dependent effects of a haloperidol challenge on energy metabolism in the normal human brain. Psychiatry Research: Neuroimaging, 60, 91-99.
12. BARTLETT, E. J., WOLKIN, A., BRODIE, J. D., LASKA, E. M., WOLF, A. P. & SANFILIPO, M. (1991b). Importance of pharmacological control in PET studies: effects of thiothixine and haloperidol on cerebral glucose utilization in chronic schizophrenia. Psychiatry Research: Neuroimaging, 40, 115-124.
13. BAXTER, L. R., PHELPS, M. E., MAZZIOTTA, J. C., GUZE, B. H., SCHWARTZ, J. M. & SELIN, C. E. (1987). Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Archives of General Psychiatry, 44, 211-218.
14. BERG, E. A. (1948). A simple objective technique for measuring flexibility in thinking. Journal of General Psychology, 39, 15-22.
15. BERMAN, K. F. & WEINBERGER, D. R. (1990). Lateralization of cortical function during cognitive tasks: regional cerebral blood flow studies of normal individuals and patients with schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry, 53, 150-160.
16. BERMAN, K. F., OSTREM, J. L., RANDOLPH, C., GOLD, J., GOLDBERG, T. E., COPPOLA, R., CARSON, R. E., HERSCOVITCH, P. & WEINBERGER, D. R. (1995). Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia, 33, 1027-1046.
17. BERMAN, K. F., RANDOLPH, C., GOLD, J., HOLT, D., JONES, D. W., GOLDBERG, T. E., CARSON, R. E., HERSCOVITCH, P. & WEINBERGER, D. R. (1991). Physiological activation of the frontal lobe studied with positron emission tomography and oxygen-15 water during working memory tasks. Journal of Cerebral Blood Flow and Metabolism, 11 (suppl. 2), 8513.
18. BERTOLINO, A., NAWROZ, S., MATTAY, V. S., BARNETT, A. S., DUYN, J. H., MOONEN, C. T. W., FRANK, J. A., TEDESCHI, G. & WEINBERGER, D. R. (1996). Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry, 153, 1554-1563.
19. BERTOLLO, D. N., COWEN, M. A. & LEVY, A. V. (1996). Hypometabolism in olfactory cortical projection areas of male patients with schizophrenia: an initial positron emission tomography study. Psychiatry Research, 60, 113-116.
20. BIVER, F., GOLDMAN, S., LUXEN, A., DELVENNE, V., DE MAERTELAER, V., DE LA FUENTE, J., MENDLEWICZ, J. & LOTSTRA, F. (1995). Altered frontostriatal relationship in unmedicated schizophrenic patients. Psychiatry Research: Neuroimaging, 61, 161-171.
21. BOOKSTEIN, F. L. (1991). Morphometric tools for landmark data: geometry and biology. New York: Cambridge University Press.
22. BRAFF, D. L., GRILLON, C. & GEYER, M. A. (1992). Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry, 49, 206-215.
23. BUCHSBAUM, M. S. (1990). The frontal lobes, basal ganglia and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin, 16, 377-387.
24. BUCHSBAUM, M. S. & HAIER, R. J. (1987). Functional and anatomical brain imaging: impact on schizophrenia research. Schizophrenia Bulletin, 13, 113-130.
25. BUCHSBAUM, M. S., CAPPELLETTI, J., BALL, R., HAZLETT, E., KING, A. C., JOHNSON, J., WU, J. & DELISI, L. E. (1984a). Positron emission tomographic image measurement in schizophrenia and affective disorders. Annals of Neurology, 15, S157-S165.
26. BUCHSBAUM, M. S., COPPOLA, R. & CAPPELLETTI, J. (1982). Positron emission tomography, EEG and evoked potential topography: new approaches to local function in pharmaco-electroencephalography, in: W. M. HERRMANN (Ed.), EEG in drug research (pp. 193-207). Stuttgart/New York: Gustav Fischer.
27. BUCHSBAUM, M. S., HAIER, R. J., POTKIN, S., NUECHTERLEIN, K., BRACHA, S., KATZ, M., LOHR, J., Wu, J., LOTTENBERG, S., JERABEK, P., TRENARY, M., TAFALLA, R., REYNOLDS, C. & BUNNEY, W. E. JR. (1992a). Frontostriatal disorder of cerebral metabolism in never medicated schizophrenics. Archives of General Psychiatry, 49, 935-942.
28. BUCHSBAUM, M. S., HOLCOMB, H. H., DELISI, L. E., CAPPELLETTI, J., KING, A. C., JOHNSON, J., HAZLETT, E., POST, R. M., MORIHISA, J., CARPENTER, W., COHEN, R., PICKAR, D. & KESSLER, R. (1984b). Anteroposterior gradients in schizophrenia and affective disorders. Archives of General Psychiatry, 41, 1159-1166.
29. BUCHSBAUM, M. S., KESSLER, R., KING, A., JOHNSON, J. & CAPPELLETTI, J. (1984c). Simultaneous cerebral glucography with positron emission tomography and topographic electroencephalography. In: G. PFURTSCHELLER, E. J. JONKMAN & F. H. LOPES DA SILVA (Eds), Brain ischemia: quantitative EEG and imaging techniques. Progress in brain research, Vol. 62 (pp. 263-269). Amsterdam: Elsevier Science Publishers B V.
30. BUCHSBAUM, M. S., POTKIN, S., MARSHALL, J. F., LOTTENBERG, S., TENG, C., HEH, C. W., TAFALLA, R., REYNOLDS, C., ABEL, L., PLON, L. & BUNNEY, W. E. JR. (1992b). Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology, 6, 155-163.
31. BUCHSBAUM, M. S., POTKIN, S., SIEGEL, B., LOHR, J., KATZ, M., GOTTSCHALK, L., GULASEKARAM, B., MARSHALL, J., LOTTENBERG, S., TENG, C. Y., ABEL, L., PLON, L. & BUNNEY, W. E. JR. (1992c). Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Archives of General Psychiatry, 49, 966-974.
32. BUCHSBAUM, M. S., SOMEYA, T., TENG, C. Y., ABEL, L., CHIN, S., NAJAFI, A., HAIER, R. J., WU, J. & BUNNEY, W. E. JR. (1996). PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry, 153, 191-199.
33. BUCHSBAUM, M. S., WU, J., SIEGEL, B. V., HACKETT, E., TRENARY, M., ABEL, L. & REYNOLDS, C. (1997). Effect of sertraline on regional metabolic rate in patients with affective disorder. Biological Psychiatry, 41, 15-22.
34. BUNNEY, B. G., BUNNEY, W. E. & CARLSSON, A. (1995). Schizophrenia and glutamate. In: R. E. BLOOM & D. J. KUPFER (Eds), Psychopharmacology: the fourth generation of progress. New York: Raven Press.
35. CARLSSON, A. (1988). The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 1, 179-186.
36. CARLSSON, M. & CARLSSON, A. (1990). Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin, 16, 425-432.
37. CASCELLA, N. G., TARAZI, F. I., SHIRAKAWA, O. & TAMMINGA, C. A. (1994). Savoxepine fails to selectively influence glucose metabolism in the rat limbic system. Psychopharmacology, 114, 275-280.
38. CHAKOS, M. H., LIEBERMAN, J. A., BILDER, R. M., BORENSTEIN, M., LERNER, G., BOGERTS, B., WU, H., KINON, B. & ASHTARI, M. (1994). Increase in caudate nuclei volume of first episode schizophrenia patients taking antipsychotic drugs. American Journal of Psychiatry, 151, 1430-1436.
39. CHUA, S. E. & MCKENNA, P. J. (1995). Schizophrenia - a brain disease? A critical review of structural and functional cerebral abnormality in the disorder. British Journal of Psychiatry, 166, 563-582.
40. CROW, T. J., FRITH, C. D., JOHNSTONE, E. C. & OWENS, D. G. (1989). Developmental arrest of cerebral asymmetries in early onset schizophrenia. Psychiatry Research, 29, 247-253.
41. DAWSON, M. E., HAZLETT, E. A., FILION, D. L., NUECHTERLEIN, K. H. & SCHELL, A. M. (1993). Attention and schizophrenia: impaired modulation of the startle reflex. Journal of Abnormal Psychology, 102, 633-641.
42. DELISI, L. E., BUCHSBAUM, M. S., HOLCOMB, H. H., LANGSTON, K. C., KING, A. C., KESSLER, R., PICKAR, D., CARPENTER, W. T., MORIHISA, J. M., MARGOLIN, R. & WEINBERGER, D. R. (1989). Increased temporal lobe glucose use in chronic schizophrenic patients. Biological Psychiatry, 25, 835-851.
43. DEQUARDO, J. R., BOOKSTEIN, F. L., GREEN, W. D. K., BRUNBERG, J. A. & TANDON, R. (1996). Spatial relationships of neuroanatomic landmarks in schizophrenia. Psychiatry Research: Neuroimaging, 67, 81-95.
44. DUFFY, F. H., BARTELS, P. B. & BURCHFIEL, J. L. (1981). Significance probability mapping: an aid in the topographic analysis of brain electrical activity. Electroencephalography, 51, 455-462.
45. FLOR-HENRY, P. (1979). Laterality, shifts of cerebral dominance, sinistrality and psychosis. In: J. GRUZELIER & P. FLOR-HENRY (Eds), Hemisphere asymmetries of function in psychopathology (pp. 3-19). Amsterdam: Elsevier/North-Holland Biomedical Press.
46. FREO, U., HOLLOWAY, H. W., GRIEG, N. H. & SONCRANT, T. T. (1992). Chronic treatment with metachlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2 (di-N-propylamino)tetralin. Psychopharmacology, 107, 30-38.
47. FREO, U., PIETRINI, P., DAM, M., PIZZOLATO, G. & BATTISTIN, L. (1993). The tricyclic antidepressant clomipramine dose dependently reduces regional cerebral metabolic rates for glucose in awake rats. Psychopharmacology, 113, 53-59.
48. FRISTON, K.J. (1995). Commentary and opinion. II. Statistical parametric mapping: ontology and current issues. Journal of Cerebral Blood Flow and Metabolism, 15, 361-370.
49. FRISTON, K. J., FRITH, C. D., LIDDLE, P. F. & FRACKOWIAK, S. J. R. (1991). Plastic transformation of PET images. Journal of Computer Assisted Tomography, 15, 634-639.
50. FRITH, C. D., FRISTON, K., LIDDLE, P. F. & FRACKOWIAK, R. S. J. (1991). Willed action and the prefrontal cortex in man: a study with PET. Proceedings of the Royal Society of London (Biology), 244, 241-246.
51. GOLDMAN-RAKIC, P. S. & SELEMON, L. D. (1986). Topography of corticostriatal projections in nonhuman primates and implications for functional parcellation of the neostriatum. In: E. G. JONES & A. PETERS (Eds), Cerebral cortex. New York: Plenum Press.
52. GRAHAM, F. K. (1975). The more or less startling effects of weak prestimulation. Psychophysiology, 12, 238-248.
53. GUR, R. E. & PEARLSON, G. D. (1993). Neuroimaging in schizophrenia research. Schizophrenia Bulletin, 19, 337-353.
54. GUR, R. C., GUR, R. E., RESNICK, S. M., SKOLNICK, B. E., ALAVI, A. & REIVICH, M. (1987). The effect of anxiety on cortical cerebral blood flow and metabolism. Journal of Cerebral Blood Flow and Metabolism, 7, 173-177.
55. GUR, R. C., MOZLEY, L. H., MOZLEY, P. D., RESNICK, S. M., KARP, J. S., ALAVI, A., ARNOLD, S. E. & GUR, R. E. (1995). Sex differences in regional cerebral glucose metabolism during a resting state. Science, 267, 528-531.
56. GUR, R. E., MOZLEY, P. D., RESNICK, S. M., MOZLEY, L. H., SHTASEL, D. L., GALLACHER, F., ARNOLD, S. E., KARP, J. S., ALAVI, A., REIVICH, M. & GUR, R. C. (1995). Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Archives of General Psychiatry, 52, 657-667.
57. HAWTON, K., SHEPSTONE, B., SOPER, N. & REZNEK, L. (1990). Single-photon emission computerised tomography (SPECT) in schizophrenia, British Journal of Psychiatry, 156, 425-427.
58. HAZLETT, E. A., BUCHSBAUM, M. S., HAZNEDAR, M. M., GERMANS, M. K. & LUU, C. (1995). Cortical-striatal - thalamic circuit analysis from PET during a startle blink paradigm, presented at the Annual Meeting of the Society for Psychophysiological Research, Toronto, Canada. Psychophysiology, 32 (Suppl.), S39.
59. HAZNEDAR, M. M., BUCHSBAUM, M. S., LUU, C., HAZLETT, E. A., SIEGEL, B. V. JR., LOHR, J., WU, J., HAIER, R. J. & BUNNEY, W. E., JR. (1997). Anterior cingulate gyrus metabolic rate decreased in schizophrenia. American Journal of Psychiatry, 154, 682-684.
60. HOLCOMB, H. H., CASCELLA, N. G., THAKER, G. K., MEDOFF, D. R., DANNALS, R. F. & TAMMINGA, C. A. (1996). Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry, 153, 41-49.
61. HOROWITZ, B. (1990). Simulating functional interactions in the brain: a model for examining correlations between regional cerebral metabolic rates. International Journal of Biomedical Computing, 26, 149-170.
62. INGVAR, D. H. & FRANZÉN, G. (1974). Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatrica Scandinavica, 50, 425-462.
63. JERNIGAN, T. L., ZATZ, L. M. & NAESER, A. (1979). Semiautomated methods for quantitating CSF volume on cranial computed tomography. Radiology, 132, 463-466.
64. KATO, T., SHIOIRI, T., MURASHITA, J., HAMAKAWA, H., INUBUSHI, T. & TAKAHASHI, S. (1995). Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Research: Neuroimaging, 61, 151-160.
65. KATZ, M., BUCHSBAUM, M. S., SIEGEL, B. V., WU, J., HAIER, R. J. & BUNNEY, W. E. JR. (1996). Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology, 33, 1-11.
66. MANN, J. J., MALONE, K. M., DIEHL, D. J., PEREL, J., COOPER, T. B. & MINTUN, M. A. (1996). Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. American Journal of Psychiatry, 153, 174-182.
67. MANSOUR, C. S., HAIER, R. J. & BUCHSBAUM, M. S. (1996). Gender comparisons of cerebral glucose metabolic rate in healthy adults during a cognitive task. Personality & Individual Differences, 20, 183-191.
68. MCINTOSH, A. R. & GONZALES-LIMA, F. (1991). Structural modeling of functional neural pathways mapped with 2-deoxyglucose: effects of acoustic startle habituation on the auditory system. Brain Research, 547, 295-302.
69. MEGA, M. S. & CUMMINGS, J. L. (1994). Frontal-subcortical circuits and neuropsychiatrie disorders. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 358-370.
70. MIURA, S. A., SCHAPIRO, M. B., GRADY, C. L., KUMAR, A., SALERNO, J. A., KOZACHUK, W. E., WAGNER, E., RAPOPORT, S. I. & HORWITZ, B. (1990). Effect of gender on glucose utilization rates in healthy humans: a positron emission tomography study. Journal of Neuroscience Research, 27, 500-504.
71. MURPHY, D. G. M., DECARLI, C., MCINTOSH, A. R., DALY, E., MENTIS, M. J., PIETRINI, P., SZCZEPANIK, J., SCHAPIRO, M. B., GRADY, C. L., HORWITZ, B. & RAPOPORT, S. I. (1996). Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Archives of General Psychiatry, 53, 585-594.
72. NORDAHL, T. E., KUSUBOV, N., CARTER, C., SALAMAT, S., CUMMINGS, A. M., O'SHORA-CELAYA, L., EBERLING, J., ROBERTSON, L., HUESMAN, R. H., JAGUST, W. & BUDINGER, T. F. (1996). Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology, 15, 541-554.
73. PEARLSON, G. D., BARTA, P. E., POWERS, R. E., MENON, R. R., RICHARDS, S. S., AYLWARD, E. H., FEDERMAN, E. B., CHASE, G. A., PETTY, R. G. & TIEN, A. Y. (1997). Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biological Psychiatry, 41, 1-14.
74. PELIZZARI, C. A., CHEN, G. T., SPELBRING, D. R., WEICHSELBAUM, R. R. & CHEN, C. T. (1989). Accurate three-dimensional registration of CT, PET, and/ or MR images of the brain. Journal of Computer Assisted Tomography, 13, 20-26.
75. PETTEGREW, J. W., KESHAVAN, M. S., PANCHALINGAM, K., STRYCHOR, S., KAPLAN, D. B., TRETTA, M. G. & ALLEN, M. (1991). Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode, drug-naive schizophrenics. Archives of General Psychiatry, 48, 563-568.
76. POLINE, J.-B. & MAZOYER, B. M. (1993). Analysis of individual positron emission tomography activation maps by detection of high signal-to-noise-ratio pixel clusters. Journal of Cerebral Blood Flow and Metabolism, 13, 425-437.
77. POTKIN, S. G., BUCHSBAUM, M. S., JIN, Y., TANG, C., TELFORD, J., FRIEDMAN, G., LOTTENBERG, S., NAJAFI, A., GULASEKARAM, B., COSTA, J., RICHMOND, G. H. & BUNNEY, W. E. JR. (1994). Clozapine effects on glucose metabolic rate in striatum and frontal cortex. Journal of Clinical Psychiatry, 55(9, suppl. B), 63-66.
78. 15O-butanol brain activation images. Human Brain Mapping, 1, 3-19.
79. ROSVOLD, H. E., MIRSKY, A. F., SARASON, I., BRANSOME, E. D. & BECK, L. H. (1956). A continuous performance test of brain damage. Journal of Consulting Psychology, 20, 343-350.
80. RUBIN, P., HOLM, S., MADSEN, P. L., FRIBERG, L., VIDEBECH, P., ANDERSEN, H. S., BENDSEN, B. B., STROMSO, N., LARSEN, J. L., LASSEN, N. A. & HEMMINGSEN, R. (1994). Regional cerebral blood flow distribution in newly diagnosed schizophrenia and schizophreniform disorder. Psychiatry Research, 53, 57-75.
81. SCHRÖDER, J., BUCHSBAUM, M. S., SIEGEL, B. V., GEIDER, F. J., LOHR, J., TANG, C., WU, J. & POTKIN, S. G. (1996). Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophrenia Research, 19, 41-53.
82. SCHRÖDER, J., BUCHSBAUM, M. S., SIEGEL, B. V., GEIDER, F. J. & NIETHAMMER, R. (1995). Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology, 28, 38-45.
83. SHIOIRI, T., KATO, T., INUBUSHI, T., MURASHITA, J. & TAKAHASHI, S. (1994). Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Research, 55, 223-235.
84. SIEGEL, B. V., BUCHSBAUM, M. S., BUNNEY, W. E., GOTTSCHALK, L. A., HAIER, R. J., LOHR, J. B., LOTTENBERG, S., NAJAFI, A., NUECHTERLEIN, K. H., POTKIN, S. G. & WU, J. C. (1993). Cortico-striatalthalamic circuits and brain glucose metabolic activity in 79 unmedicated male schizophrenics. American Journal of Psychiatry, 150, 1325-1336.
85. SWERDLOW, N. R. & KOOB, G. F. (1987). Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-pallido-trialamic function. Behavioral and Brain Sciences, 10, 197-245.
86. SZYMANSKI, S., GUR, R. C., GALLACHER, F., MOZLEY, L. H. & GUR, R. E. (1996). Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism. Neuropsychopharmacology, 15, 567-575.
87. TALAIRACH, J. & TOURNOUX, P. (1988). Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers.
88. TAMMINGA, C. A., THAKER, G. K., BUCHANAN, R., KIRKPATRICK, B., ALPHS, L., CHASE, T. & CARPENTER, W. (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry, 49, 522-530.
89. VITA, A., BRESSI, S., PERANI, D., INVERNIZZI, G., GIOBBIO, G. M., MASSIMILIANO, D., GARBARINI, M., SOLE, A. D. & FAZIO, F. (1995). High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients. American Journal of Psychiatry, 152, 876-882.
90. VOLKOW, N. D., GILLESPIE, H., MULLANI, N., TANCREDI, L., GRANT, C., VALENTINE, A. & HOLLISTER, L. (1996). Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Research: Neuroimaging, 67, 29-38.
91. 2 receptors. American Journal of Psychiatry, 154, 50-55.
92. WILLIAMSON, P., DROST, D., STANLEY, J., CARR, T., MORRISON, S. & MERSKEY, H. (1991). Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Archives of General Psychiatry, 48, 578.
93. WOLKIN, A., SANFILIPO, M., ANGRIST, B., DUNCAN, E., WIELAND, S., WOLF, A. P., BRODIE, J. D., COOPER, T. B., LASKA, E. & ROTROSEN, J. P. (1994). Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology. Biological Psychiatry, 36, 317-325.
94. WOLKIN, A., SANFILIPO, M., DUNCAN, E., ANGRIST, B., WOLF, A., COOPER, T., BRODIE, J., LASKA, E. & ROTROSEN, J. (1996). Blunted changes in cerebral glucose utilization after haloperidol treatment in schizophrenic patients with prominent negative symptoms. American Journal of Psychiatry, 153, 346-354.
95. WOLKIN, A., SANFILIPO, M., WOLF, A. P., ANGRIST, B., BRODIE, J. D. & ROTROSEN, J. (1992). Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry, 49, 959-965.
96. YOSHII, F., BARKER, W. W., CHANG, J. Y., LOEWENSTEIN, D., APICELLA, A., SMITH, D., BOOTHE, T., GINSBERG, M. D., PASCAL, S. & DUARA, R. (1988). Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. Journal of Cerebral Blood Flow and Metabolism, 8, 654-661.